Thus, Zhang et al. [52] reported that XRCC1 Arg194Trp polymorphism was not a risk factor for glioma risk in a Chinese population, which was the opposite of the conclusions made in a previous study [51]. Here, XRCC1 is linked to central nervous system cancer.